Woodline Partners LP Imara Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.11 - $2.42 $94,225 - $205,428	-84,888 Reduced 8.92%	866,405 $1.98 Million
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $72,986 - $137,863	-73,724 Reduced 7.19%	951,293 $1.16 Million
Q1 2022 May 16, 2022	BUY	$1.15 - $2.41 $844,768 - $1.77 Million	734,581 Added 252.92%	1,025,017 $1.93 Million
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.05 $351,612 - $632,901	156,272 Added 116.48%	290,436 $653,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $547,389 - $1.05 Million	134,164 New	134,164 $547,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.